Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,643 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW)

NCT06177574

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Hospital Universitario Virgen de Las Nieves Granada, Andalusia, Spain
  • H JEREZ Jerez de la Frontera, Cádiz, Spain
  • Hospital Universitario Torrecárdenas Almería, Spain
  • Hospital Universitario Puerto Real, INIBICA, Cadiz, Spain
View all 15 locations
View Trial Details
Completed

A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV Envelope Protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in Healthy, HIV-1 Uninfected Adults

NCT03699241

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • MGH Boston, Massachusetts, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Kenya AIDS Vaccine Initiative Nairobi, Kenya
View Trial Details
Completed

2000 HIV Human Functional Genomics Partnership Program

NCT03994835

Conditions
Blood-Borne Infections, Cardiovascular Diseases, Communicable Diseases, +19 more
Locations
  • Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands
  • Radboudumc Nijmegen, Netherlands
  • Erasmus MC Rotterdam, Netherlands
  • Elisabeth Twee-Steden ziekenhuis Tilburg, Netherlands
View Trial Details
Completed

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)

NCT02831764

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 105 locations
View Trial Details

Related conditions